![](/img/cover-not-exists.png)
A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil
Katsumasa Kuroi, Akihiko Osaki, Hiroyuki Kawami, Shigeru Murakami, Tetsuya TogeVolume:
4
Language:
english
Pages:
5
DOI:
10.1007/bf02967064
Date:
July, 1997
File:
PDF, 374 KB
english, 1997